Posted on 16306
Kroll Bond Rating Agency (KBRA) releases an update on the residential solar loan ABS sector, including a 2021 new issuance forecast, credit and competitive trends across the sector, and a comparison of solar loan ABS platforms.
Credit performance in the residential solar loan ABS sector has shown resilience through the COVID-19 pandemic and appears likely to remain stable in 2021. Originations continue to rise as issuers are becoming more competitive in their product offerings. In addition, the industry may be further buoyed by federal policies from a new administration that has indicated its support of renewable energy.
As a result of positive trends in the sector, KBRA expects residential solar ABS issuance from public transactions to reach over $2 billion in 2021. Other positive drivers include the sector’s favorable credit performance, yield, and positive ESG attributes.
Kroll Bond Rating Agency: KBRA Assigns Rating to Oban Cards 2021-1 PLC
Kroll Bond Rating Agency UK Limited (KBRA) assigns a rating to the Series 2021-1 Class A Notes relating to the Oban Card 2021-1 PLC transaction, a £451.3 million securitisation of United Kingdom ( UK ) non-prime credit card receivables originated by Vanquis Bank Limited ( Vanquis Bank ).
Vanquis Bank offers a range of credit card products, unsecured personal loans and savings products. Vanquis Bank is a leading issuer of credit cards in the UK non-standard credit market, offering credit cards to customers who have typically been declined by mainstream credit card providers. Vanquis Bank has been active in the credit card market in the UK since 2003 and is wholly-owned by Provident Financial PLC ( Provident ), which was established in 1880.
ChemoCentryx to Participate in Two Upcoming Investor Conferences
ChemoCentryx to Participate in Two Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., Jan. 06, 2021 ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences and participate in a panel discussion hosted by former FDA Commissioner, Scott Gottlieb, M.D.:
39th Annual J.P. Morgan Healthcare Conference Wednesday, January 13 at 11:40 a.m. Eastern Time
H.C. Wainwright Virtual BioConnect Conference On-demand presentation available beginning Monday, January 11 at 6:00 a.m. Eastern Time
Clinical
Discussion
at the H.C. Wainwright Virtual BioConnect Conference Monday, January 11 at 12:00 p.m. Eastern Time